Provision was formed out of the passion to develop new, innovative, comprehensive healthcare product and service solutions that will make major improvements in patient care, outcomes, and value. The Provision founders have made significant impact in the local healthcare community and the world by developing and commercializing the world’s first PET scanners allowing for early diagnosis of cancer which is now a standard clinical tool throughout the world. Provision continues this passion for innovative healthcare product and service solutions and is currently offering a wide range of exciting job opportunities in all areas of healthcare and medical device manufacturing. Opportunities at provision include diagnostic imaging, radiation therapy, proton therapy, product development, and management services.
Provision established ProNova Solutions in 2011 to meet the needs of cancer patients by making Proton Therapy accessible to a greater number of patients and physicians throughout the world. ProNova is aggressively developing the next generation of this advanced cancer treatment by delivering a lower-cost, smaller, lighter, more energy efficient solution without sacrificing performance and improving upon existing capabilities. The fusion of state-of-the-art imaging, multi-axis precision positioning, superconducting magnet technology, and unprecedented closed loop treatment verification using Positron Emission Tomography brings ProNova customers clinical, operational, and financial benefits that will make major improvements in patient care, outcomes, and value.